HomeNDC LookupRxCUI directory › RxCUI 1424219

6 ML radium chloride Ra-223 30 MCI/ML Injection [Xofigo] — RxCUI 1424219

RxNorm drug concept · Semantic branded drug
RxCUI 1424219 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1424219
Official name6 ML radium chloride Ra-223 30 MCI/ML Injection [Xofigo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXofigo 178 MCI per 6 ML Injection; Xofigo 1100 kBq/ML in 6 ML Injection; Xofigo (radium Ra-223 dichloride) 6600 kBq per 6 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 6 ML radium chloride Ra-223 30 MCI/ML Injection... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 6 ML radium chloride Ra-223 30 MCI/ML Injection [Xofigo] RxCUI 1424219

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Radium 1546450
    • Radium chloride Ra-223 1424174
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xofigo 1424215
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Radium Injection 2587439
    • Radium chloride Ra-223 Injection 2647643
    • Radium Injectable Product 2587447
    • Radium chloride Ra-223 Injectable Product 2660153
    • Radium Injection [Xofigo] 2587444
    • Radium chloride Ra-223 Injection [Xofigo] 2658055
    • Xofigo Injectable Product 1424218
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 6 ML radium chloride Ra-223 30 MCI/ML Injection SCD · 1424214
  • Radium chloride Ra-223 30 MCI/ML SCDC · 1745391
  • Radium Injection SCDF · 2587439
  • Radium chloride Ra-223 Injection SCDFP · 2647643
  • Radium Injectable Product SCDG · 2587447
  • Radium chloride Ra-223 Injectable Product SCDGP · 2660153

Brand-Name Concepts

  • Radium chloride Ra-223 30 MCI/ML [Xofigo] SBDC · 1745393
  • Radium Injection [Xofigo] SBDF · 2587444
  • Radium chloride Ra-223 Injection [Xofigo] SBDFP · 2658055
  • Xofigo Injectable Product SBDG · 1424218
  • Xofigo BN · 1424215

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1424219 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0208-01 6 mL in 1 VIAL, SINGLE-DOSE (50419-208-01) Xofigo Bayer HealthCare Pharmaceuticals Inc. 2013-05-20
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.